AARD vs AMGN: Which Stock is Better?

Side-by-side comparison of Aardvark Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

AARD

Aardvark Therapeutics Inc

$15.52

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricAARDAMGNWinner
Market Cap$334.66M$177.92BAMGN
P/E RatioN/A25.57AMGN
EPS (TTM)$N/A$12.92AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.1%AMGN

Analyze AARD

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AARD or AMGN a better investment?

Comparing AARD and AMGN: Aardvark Therapeutics Inc has a market cap of $334.66M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AARD and AMGN?

AARD (Aardvark Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AARD or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: AARD or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for AARD.

Which company is more profitable: AARD or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 0.0% for AARD.

Which is the larger company: AARD or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $334.66M for AARD.

Should I buy AARD or AMGN in 2026?

Both AARD and AMGN have investment merit. AARD trades at $15.52 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AARD and AMGN stock?

Key differences: Market Cap ($334.66M vs $177.92B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.1%).

Popular Stock Comparisons